Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : AZN crawled date : 2022 - 05 - 16 save search
Global RSV Vaccine and Antibody Pipeline Market: Compound Annual Growth of 38.9% Forecast During 2024-2028
Published: 2022-05-16 (Crawled : 19:00) - prnewswire.com
AZNCF | News | $138.73 1.86% -4.19% 3.6K
|
Health Technology
|
| O: 4.22%
H: 0.0%
C: -2.05%
JNJ | News | $149.12 0.82% 0.3% 7.2M
|
Health Technology
|
| O: 1.08%
H: 0.0%
C: 0.0%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: 1.5%
H: 0.64%
C: 0.19%
AZN | News | $70.13 2.31% 2.24% 4.3M
|
Health Technology
|
| O: 3.17%
H: 0.0%
C: 0.0%
antibody vaccine growth
Global Report on Europe precision medicine Market Size & Share Worth USD 27469 Million, to Record a 10.7% CAGR by 2028 | Europe precision medicine Industry Trends, Segmentation, Analysis & Forecast by Zion Market Research
Published: 2022-05-16 (Crawled : 17:00) - prnewswire.com
AZNCF | News | $138.73 1.86% -4.19% 3.6K
|
Health Technology
|
| O: 1.73%
H: 0.86%
C: -1.11%
TMO | News | $548.38 0.66% 0.29% 1.5M
|
Health Technology
|
| O: -0.22%
H: 0.0%
C: 0.0%
NVS | News | $95.12 0.81% -1.18% 2.4M
|
Health Technology
|
| O: 1.04%
H: 0.0%
C: 0.0%
MDT | $80.57 1.37% 0.0% 3.8M
|
Health Technology
|
| O: -0.25%
H: 2.28%
C: 1.77%
LH M | $203.07 0.79% 0.29% 690K
|
Health Services
|
| O: -0.59%
H: 0.58%
C: -0.32%
AZN | News | $70.13 2.31% 2.24% 4.3M
|
Health Technology
|
| O: 1.52%
H: 0.0%
C: 0.0%
europe research report market
NeoGenomics Appoints Lynn Tetrault Interim CEO
Published: 2022-05-16 (Crawled : 12:00) - biospace.com/
AZNCF | News | $138.73 1.86% -4.19% 3.6K
|
Health Technology
|
| O: 1.73%
H: 0.86%
C: -1.11%
NEO | $13.42 -0.81% -0.74% 800K
|
Health Services
|
| O: 13.56%
H: 1.47%
C: -6.7%
AZN | News | $70.13 2.31% 2.24% 4.3M
|
Health Technology
|
| O: 1.52%
H: 0.0%
C: 0.0%
ceo
Proteros Expands Oncology Collaboration and License Agreement with AstraZeneca
Published: 2022-05-16 (Crawled : 11:00) - biospace.com/
AZN | News | $70.13 2.31% 2.24% 4.3M
|
Health Technology
|
| O: 1.52%
H: 0.0%
C: 0.0%
collaboration license
Anticoagulant Reversal Drugs Market - 2022-2026 | Increasing Prevalence of Coagulation Disorders to Boost Market Growth | Technavio
Published: 2022-05-16 (Crawled : 06:00) - prnewswire.com
AZNCF | News | $138.73 1.86% -4.19% 3.6K
|
Health Technology
|
| O: 1.73%
H: 0.86%
C: -1.11%
BHC | $8.45 -2.76% 0.0% 2.4M
|
Health Technology
|
| O: 1.99%
H: 0.0%
C: 0.0%
AZN | News | $70.13 2.31% 2.24% 4.3M
|
Health Technology
|
| O: 1.52%
H: 0.0%
C: 0.0%
growth market drug
Gainers vs Losers
| 74% | 26% |
Top 10 Gainers
MTTR | News M | $4.8 175.86% 63.6% 71M
|
AGBA | $2.5 100.0% 56.6% 200M
|
Finance
MLEC | $2.47 76.43% 42.62% 78M
|
n/a
EDBL | News | $6.26 66.49% 40.13% 16M
|
ATGL | $2.86 46.25% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.7M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.